Understanding the Impact of ICH E6 on Your GCP Quality and Compliance Program
Quality Assurance (QA) in Clinical Development has significantly changed over the past two decades. The US Code of Federal Regulations (CFR) initially did not explicitly mandate a system for managing quality throughout all stages of the clinical trial process. However, developing the FDA’s Bioresearch Monitoring (BIMO) Program and subsequent international standards has transformed the landscape […]
